Current and historical daily PE Ratio for Advagene Biopharma Co Ltd (
ROCO:6709
) from 2018 to Jun 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Advagene Biopharma stock (ROCO:6709) PE ratio as of Jun 23 2024 is 0.
More Details
Advagene Biopharma Co Ltd (ROCO:6709) PE Ratio (TTM) Chart
Advagene Biopharma Co Ltd (ROCO:6709) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1216
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Advagene Biopharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-23 | At Loss | 2024-04-18 | At Loss |
| 2024-06-21 | At Loss | 2024-04-17 | At Loss |
| 2024-06-20 | At Loss | 2024-04-16 | At Loss |
| 2024-06-19 | At Loss | 2024-04-15 | At Loss |
| 2024-06-18 | At Loss | 2024-04-12 | At Loss |
| 2024-06-17 | At Loss | 2024-04-11 | At Loss |
| 2024-06-14 | At Loss | 2024-04-10 | At Loss |
| 2024-06-13 | At Loss | 2024-04-09 | At Loss |
| 2024-06-12 | At Loss | 2024-04-08 | At Loss |
| 2024-06-11 | At Loss | 2024-04-03 | At Loss |
| 2024-06-07 | At Loss | 2024-04-02 | At Loss |
| 2024-06-06 | At Loss | 2024-04-01 | At Loss |
| 2024-06-05 | At Loss | 2024-03-29 | At Loss |
| 2024-06-04 | At Loss | 2024-03-28 | At Loss |
| 2024-06-03 | At Loss | 2024-03-27 | At Loss |
| 2024-05-31 | At Loss | 2024-03-26 | At Loss |
| 2024-05-30 | At Loss | 2024-03-25 | At Loss |
| 2024-05-29 | At Loss | 2024-03-22 | At Loss |
| 2024-05-28 | At Loss | 2024-03-21 | At Loss |
| 2024-05-27 | At Loss | 2024-03-20 | At Loss |
| 2024-05-24 | At Loss | 2024-03-19 | At Loss |
| 2024-05-23 | At Loss | 2024-03-18 | At Loss |
| 2024-05-22 | At Loss | 2024-03-15 | At Loss |
| 2024-05-21 | At Loss | 2024-03-14 | At Loss |
| 2024-05-20 | At Loss | 2024-03-13 | At Loss |
| 2024-05-17 | At Loss | 2024-03-12 | At Loss |
| 2024-05-16 | At Loss | 2024-03-11 | At Loss |
| 2024-05-15 | At Loss | 2024-03-08 | At Loss |
| 2024-05-14 | At Loss | 2024-03-07 | At Loss |
| 2024-05-13 | At Loss | 2024-03-06 | At Loss |
| 2024-05-10 | At Loss | 2024-03-05 | At Loss |
| 2024-05-09 | At Loss | 2024-03-04 | At Loss |
| 2024-05-08 | At Loss | 2024-03-01 | At Loss |
| 2024-05-07 | At Loss | 2024-02-29 | At Loss |
| 2024-05-06 | At Loss | 2024-02-27 | At Loss |
| 2024-05-03 | At Loss | 2024-02-26 | At Loss |
| 2024-05-02 | At Loss | 2024-02-23 | At Loss |
| 2024-04-30 | At Loss | 2024-02-22 | At Loss |
| 2024-04-29 | At Loss | 2024-02-21 | At Loss |
| 2024-04-26 | At Loss | 2024-02-20 | At Loss |
| 2024-04-25 | At Loss | 2024-02-19 | At Loss |
| 2024-04-24 | At Loss | 2024-02-16 | At Loss |
| 2024-04-23 | At Loss | 2024-02-15 | At Loss |
| 2024-04-22 | At Loss | 2024-02-05 | At Loss |
| 2024-04-19 | At Loss | 2024-02-02 | At Loss |
Advagene Biopharma Co Ltd (ROCO:6709) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Advagene Biopharma Co Ltd
ISIN : TW0006709009
Share Class Description:
ROCO:6709: Ordinary SharesDescription
Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based drug developer. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray influenza vaccine (LT-Flu), allergy vaccines (LT-Allergy), and other vaccines.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers